Home » High-Quality Health Information » Health Topics » Hemolytic Anemia » Study: NCT01085201

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
Status:	Recruiting participants
Conditions:	Sickle Cell Disease
Interventions:	Drug: Lexiscan
Institutions:	Brigham and Women's Hospital, Children's Hospital Boston, Dana-Farber Cancer Institute
Health Topics:	Hemolytic Anemia, Sickle Cell Anemia
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012